Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy

29Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background:Immune hyperactivation in immunodiscordant patients can induce residual HIV replication and limit CD4Tcell recovery. We assessed theimpact of raltegravir intensification onCD4 T cell recoveryandviral persistence.Methods: We performed a randomized, controlled, pilot trial. Patients with CD4 T cell counts <350 cells/mm3 despite suppressive antiretroviral therapy were randomized (2:1) to intensify with raltegravir (intensified arm, n=30) or to continue with the same regimen (control arm, n=14) for 48 weeks. Then, the control individuals intensified their treatment for 24 weeks (delayed-intensification arm). We analysed changes in CD4 T cell counts, total and episomal HIV DNA in peripheral blood mononuclear cells and predictive factors for response.Results: Raltegravir intensification induced a rapid increase in CD4 Tcell counts (week 12) (P=0.007), although this was not sustained over time. Control patients maintained constant but slowincreases in CD4 Tcell counts (present in the pre-study period), reaching CD4 Tcell counts similar to those of patients in the intensificationarmatweek 48. This effectwas confirmed by the analysis of the delayed-intensification arm. Proviral DNA levels remained stable in both arms over time; episomal DNA forms and ultrasensitive plasma viral load were barely detected during the study. Increases in CD4 T cell counts were associated with low baseline CD95 expression in CD4 and CD8 T cells (P=0.020).Conclusions: Raltegravir intensification modestly impacts viral dynamics and induces a rapid but limited gain in CD4 T cell counts in immunodiscordant patients. Residual viral replication does not seem to be the main cause of unsatisfactory CD4 T cell recovery in these patients. © The Author 2013. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.

Cite

CITATION STYLE

APA

Negredo, E., Massanella, M., Puertas, M. C., Buzón, M. J., Puig, J., Pérez-Alvárez, N., … Blanco, J. (2013). Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy. Journal of Antimicrobial Chemotherapy, 68(10), 2358–2362. https://doi.org/10.1093/jac/dkt183

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free